Note: Compounded tirzepatide is not approved by the U.S
[1] [5] Research into transdermal delivery of peptide medications faces significant challenges due to the large molecular size of GLP-1 analogs and the skin's natural barrier function
But here is what the ads dont tell you: smaller doses havent been studied extensively in large clinical trials, there is no evidence that microdosing is safe and effective, and microdosing comes with real safety risks, including dosing errors
If the bursa is infected, there also will be prominent redness and the skin will feel very warm
YesMedicare Can Now Cover Foundayo for Weight Loss As of July 1, 2026, Medicare covers Foundayo for weight loss through the new Medicare GLP-1 Bridge a flat $50/month , covering all Foundayo formulations , for Part D beneficiaries who meet the BMI-based eligibility criteria